Clinical Trials Browser

Phase 2 × OTHER × HCC × Clear all

NCT06823375 2026-03-04

SBRT With Immunotherapy and Atezo-Bev in HCC With Major Portal Vein Thrombosis

Phase 2 Recruiting

HCC

NCT06413017 2024-05-14

Nimotuzumab Combined With ICIs for the Treatment of Advanced Liver Cancer After First Line Treatment Failure

Phase 2 Recruiting

HCC

NCT04123340 2023-01-06

IAMCOMPLETE

Phase 2 Completed

HCC